semaglutide dvt risk Carrying excess weight is a known factor for blood clots, but could GLP-1 medications like Ozempic, Wegovy, and Mounjaro help lower that risk? New research suggests they might. Join us for Glucagon-like peptide-1 receptor agonists are

Foundayo (orforglipron) produces around 12% average weight loss in its pivotal trial, with some patients losing up to 15%

B-12 is involved in the process that converts food into energy, so it gives people an energy boost

Upright positioning may reduce reflux and regurgitation

As access becomes more direct, -

Additional research has explored its effects on gastrointestinal motility and metabolic signaling

There are new lines of evidence that endogenous synthesis of creatine is not sufficient for humans under many physiological (e.g., exercise, pregnancy and lactation) and pathological (e.g., tissue injury, ischemia, and diabetes) conditions